Related references
Note: Only part of the references are listed.Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity
Lisa-Marie Greenwood et al.
PSYCHOPHARMACOLOGY (2022)
Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice
Junhan Liu et al.
BEHAVIOURAL PHARMACOLOGY (2022)
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney et al.
PSYCHOPHARMACOLOGY (2022)
Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice
Rose Chesworth et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cassio Morais Loss et al.
FRONTIERS IN PHARMACOLOGY (2021)
Effects of handling on the behavioural phenotype of the neuregulin 1 type III mouse model for
Stefan Guerra et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
Hayley F. North et al.
TRANSLATIONAL PSYCHIATRY (2021)
Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum
Joao F. C. Pedrazzi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes
Fabian Kreilaus et al.
GENES BRAIN AND BEHAVIOR (2020)
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies
Julie Schoevers et al.
CURRENT OPINION IN PSYCHIATRY (2020)
Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces A beta(40) Levels in 12-Month-Old Male A beta PPswe/PS1 Delta E9 Transgenic Mice
Georgia Watt et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
Naielly Rodrigues da Silva et al.
PHARMACOLOGICAL RESEARCH (2020)
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
E. Appiah-Kusi et al.
PSYCHOPHARMACOLOGY (2020)
Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice
Pabitra Hriday Patra et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy
Georgia Watt et al.
NEUROSCIENCE (2020)
Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice
Georgia Watt et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe /PS1ΔE9 Transgenic Female Mice
Madilyn Coles et al.
FRONTIERS IN PHARMACOLOGY (2020)
Comparison of cannabidiol to citalopram in targeting fear memory in female mice
Zackary T. Montoya et al.
JOURNAL OF CANNABIS RESEARCH (2020)
Functional effects of synthetic cannabinoids versus Δ9-THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression
Shaul Schreiber et al.
ADDICTION BIOLOGY (2019)
Age-related changes in neuroinflammation and prepulse inhibition in offspring of rats treated with Poly I:C in early gestation
Shuang Ding et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2019)
Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice
Eva M. Schleicher et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats
John Shallcross et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders
Ashleigh L. Osborne et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors
Alice Hartmann et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
Robin Wilson et al.
TRANSLATIONAL PSYCHIATRY (2019)
First behavioural assessment of a novel Immp2l knockdown mouse model with relevance for Gilles de la Tourette syndrome and Autism spectrum disorder
Fabian Kreilaus et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Nadia Solowij et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia
Ashleigh L. Osborne et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation
Cristina A. J. Stern et al.
NEUROSCIENCE (2018)
Brain morphologic changes in early stages of psychosis: Implications for clinical application and early intervention
Tsutomu Takahashi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
Ashleigh L. Osborne et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Adolescent Stress as a Driving Factor for Schizophrenia Development-A Basic Science Perspective
Felipe V. Gomes et al.
SCHIZOPHRENIA BULLETIN (2017)
Neuroanatomical Substrates of Rodent Social Behavior: The Medial Prefrontal Cortex and Its Projection Patterns
Jaewon Ko
FRONTIERS IN NEURAL CIRCUITS (2017)
Altered cytokine profile, pain sensitivity, and stress responsivity in mice with co-disruption of the developmental genes Neuregulin-1 x DISC1
Lieve Desbonnet et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Effects of early adolescent environmental enrichment on cognitive dysfunction, prefrontal cortex development, and inflammatory cytokines after early life stress
Carine H. do Prado et al.
DEVELOPMENTAL PSYCHOBIOLOGY (2016)
Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2016)
The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia
Peijun Ju et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Neuregulin-1 and schizophrenia in the genome-wide association study era
Md Shaki Mostaid et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats
Erica Zamberletti et al.
PHARMACOLOGICAL RESEARCH (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
Felipe V. Gomes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex
Tiziana Rubino et al.
NEUROBIOLOGY OF DISEASE (2015)
Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse
Leonora E. Long et al.
PLOS ONE (2015)
A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
Kyra-Verena Sendt et al.
PSYCHIATRY RESEARCH (2015)
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
J. F. C. Pedrazzi et al.
PSYCHOPHARMACOLOGY (2015)
Novel behavioural characteristics of female APPSwe/PS1 ΔE9 double transgenic mice
David Cheng et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia
Christina A. Wilson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
David Cheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Downregulation of Neuregulin 1-ErbB4 Signaling in Parvalbumin Interneurons in the Rat Brain May Contribute to the Antidepressant Properties of Ketamine
Nan Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit
C. Barkus et al.
MOLECULAR PSYCHIATRY (2014)
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1aΔE9 mice
David Cheng et al.
PSYCHOPHARMACOLOGY (2014)
Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex
Tariq W. Chohan et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence
Leonora E. Long et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2013)
Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin
Guel Doelen et al.
NATURE (2013)
A NEUREGULIN 1 TRANSMEMBRANE DOMAIN MUTATION CAUSES IMBALANCED GLUTAMATERGIC AND DOPAMINERGIC RECEPTOR EXPRESSION IN MICE
K. A. Newell et al.
NEUROSCIENCE (2013)
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models
Tim Karl
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2013)
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Kyoko Higashi et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Cognition in female transmembrane domain neuregulin 1 mutant mice
Rose Chesworth et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Linkage Analysis Followed by Association Show NRG1 Associated with Cannabis Dependence in African Americans
Shizhong Han et al.
BIOLOGICAL PSYCHIATRY (2012)
Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: A putative model of gene x environment interaction
Lieve Desbonnet et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
The role of habituation in hippocampus-dependent spatial working memory tasks: Evidence from GluA1 AMPA receptor subunit knockout mice
David J. Sanderson et al.
HIPPOCAMPUS (2012)
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats
Anand Gururajan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?
Chris Barkus et al.
NEUROPHARMACOLOGY (2012)
Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
Leonora E. Long et al.
PLOS ONE (2012)
Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?
T. Karl et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids
Aurelie A. Boucher et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders
Mia Thompson et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Christian D. Schubart et al.
SCHIZOPHRENIA RESEARCH (2011)
A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
Leonora E. Long et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Spatial working memory deficits in GluA1 AMPA receptor subunit knockout mice reflect impaired short-term habituation: Evidence for Wagner's dual-process memory model
David J. Sanderson et al.
NEUROPSYCHOLOGIA (2010)
COGNITION IN TRANSMEMBRANE DOMAIN NEUREGULIN 1 MUTANT MICE
L. Duffy et al.
NEUROSCIENCE (2010)
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
Matthijs G. Bossong et al.
PROGRESS IN NEUROBIOLOGY (2010)
A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice
Leonora E. Long et al.
PSYCHOPHARMACOLOGY (2010)
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Maarten van den Buuse
SCHIZOPHRENIA BULLETIN (2010)
Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation
Maarten van den Buuse et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
Daniel Thomas Malone et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Emilio Fernandez-Espejo et al.
PSYCHOPHARMACOLOGY (2009)
Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism
Kazuhide Hayakawa et al.
NEUROPHARMACOLOGY (2008)
Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1
Colm M. P. O'Tuathaigh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Gene-Environment Interplay Between Cannabis and Psychosis
Cecile Henquet et al.
SCHIZOPHRENIA BULLETIN (2008)
Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia
T. Karl et al.
GENES BRAIN AND BEHAVIOR (2007)
Metabolic side effects of antipsychotic medication
A. Tschoner et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol
A. A. Boucher et al.
PSYCHOPHARMACOLOGY (2007)
Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats
Nicole L. Schramm-Sapyta et al.
PSYCHOPHARMACOLOGY (2007)
A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia
Consuelo Walss-Bass et al.
BIOLOGICAL PSYCHIATRY (2006)
Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice
LE Long et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders
Schahram Akbarian et al.
BRAIN RESEARCH REVIEWS (2006)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
FA Moreira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats
JM Shoemaker et al.
NEUROSCIENCE (2005)
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence
M Lambert et al.
EUROPEAN PSYCHIATRY (2004)
Neuregulin 1 and susceptibility to schizophrenia
H Stefansson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder -: A postmortem brain study
A Guidotti et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
